Respiratory Failure clinical trials

Explore recruiting respiratory failure clinical trials.

Recruiting respiratory failure studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Respiratory Failure trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase III, Multicentre, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Tozorakimab (MEDI3506) in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen (TILIA)

France, Sweden, Bulgaria, Romania, Greece, Italy +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Non-Invasive Ventilation versus High Flow Oxygenotherapy in Patients at High Risk of Extubation Failure

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Efficacy of Higher vs. Lower Doses of Dexamethasone in Patients With Acute Hypoxemic Respiratory Failure (Including ARDS) Caused by Infections (Including COVID-19)

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Apneic oxygenation with high-flow nasal oxygenation after preoxygenation with noninvasive ventilation before intubation in hypoxemic patients in intensive care unit. A multicenter randomized controlled trial.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Evaluation of frequency occurrence persistent pulmonary hypertension of newborns in group of newborns born between 32 and 42 weeks of pregnancy treated by salbutamol

Poland

Phase III and phase IV (Integrated) EU CTIS Study details

“Efficacy and safety of 72-hour infusion of Prostacyclin (1 ng/kg/min) in mechanically ventilated patients with infectious pulmonary endotheliopathy – a multicentre randomized, placebo-controlled, blinded, investigator-initiated trial” (COMBAT-ARF).

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Respiratory Failure trials by city

Respiratory Failure in Toronto Respiratory Failure in Vancouver Respiratory Failure in Montreal Respiratory Failure in Calgary Respiratory Failure in Edmonton Respiratory Failure in Ottawa Respiratory Failure in Winnipeg Respiratory Failure in Quebec City Respiratory Failure in Hamilton Respiratory Failure in Kitchener Respiratory Failure in London Respiratory Failure in Halifax Respiratory Failure in New York Respiratory Failure in Los Angeles Respiratory Failure in Chicago Respiratory Failure in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease